Next Article in Journal
Cytotoxic Compounds from the Saudi Red Sea Sponge Xestospongia testudinaria
Previous Article in Journal
Antibacterial Derivatives of Marine Algae: An Overview of Pharmacological Mechanisms and Applications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi

College of Life Science, Dalian Nationalities University, No. 18, LiaoHe West Road, Dalian 116600, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2016, 14(4), 76; https://doi.org/10.3390/md14040076
Submission received: 27 January 2016 / Revised: 11 March 2016 / Accepted: 29 March 2016 / Published: 22 April 2016

Abstract

:
In recent years, a considerable number of structurally unique metabolites with biological and pharmacological activities have been isolated from the marine-derived fungi, such as polyketides, alkaloids, peptides, lactones, terpenoids and steroids. Some of these compounds have anticancer, antibacterial, antifungal, antiviral, anti-inflammatory, antioxidant, antibiotic and cytotoxic properties. This review partially summarizes the new bioactive compounds from marine-derived fungi with classification according to the sources of fungi and their biological activities. Those fungi found from 2014 to the present are discussed.

Graphical Abstract

1. Introduction

The oceans, which cover more than 70% of the earth’s surface and more than 95% of the earth’s biosphere, harbor various marine organisms. Because of the special physical and chemical conditions in the marine environment, almost every class of marine organism displays a variety of molecules with structurally unique features. However, unlike the long historical medical uses of terrestrial plants, marine organisms have a shorter history in pharmacological application [1]. In recent years, a significant number of novel metabolites with pharmacological potential have been discovered from marine organisms, such as polyketides, alkaloids, peptides, proteins, lipids, shikimates, glycosides, isoprenoids and hybrids, which exhibit biological activity including anticancer, antitumor, antiproliferative, antimicrotubule, cytotoxic, photo protective, as well as antibiotic and antifouling properties [2]. Among them, marine microorganisms, such as bacteria, actinomycetes, fungi and cyanobacteria have attracted more attention as potential lead compound producers. In comparison to marine invertebrates, they are a renewable and a reproducible source, as they can be cultured and can even be envisaged as amazing microbial factories for natural products [3].
Previously, scientists always focused on actinomycetes for their abilities to produce antibiotics. In fact, many fungal metabolites in the pharmaceutical market indicates the potential of microorganisms as valuable sources of lead drugs, e.g., the antibiotic polyketide griseofulvin (Likuden M®), the antibacterial terpenoid fusidic acid (Fucidine®), semi-synthetic or synthetic penicillins and cephalosporins, macrolides, statins as well as the ergot alkaloids such as ergotamine (Ergo-Kranit®) [4]. In 1949, the first secondary metabolite isolated from a marine-derived fungal strain, famous cephalosporin C, was produced by a culture of a Cephalosporium sp. isolated from the Sardinian coast. However, this was a more or less accidental discovery.
Despite the discovery of such important drug from marine fungi, the number of bioactive natural products originated from marine fungi increased extremely slowly. It is only from the late 1980s that researchers have focused on marine-derived fungi. In fact, marine-derived fungi are very important sources for novel bioactive secondary metabolites that could potentially be used as drugs. Blunt et al., mentioned that marine-derived fungi have a greater proportion of marine natural compounds with more desirable oral-bioavailability and physico-chemical properties with molecular weight (MW) < 400 and clogP (calculated octanol-water logP) < 4 [5]. Compounds that meet these criteria can suggest the optimum combinations for potential pharmaceuticals [5]. Currently, thousands of structurally unique and biologically active compounds have been reported from marine fungi.
According to a classical definition, marine fungi are divided into obligate marine fungi and facultative marine fungi [6]. In fact, marine fungi often live as symbionts in algae, mangrove, coral, sea anemone, starfish, sea urchin, seagrass, and, especially, sponges. Collection of marine fungi usually requires the collection of the host or supporting material (e.g., algae, marine invertebrates, sediment or water, and even driftwood). Herein, a neutral term “marine-derived fungi” was used, which includes any fungal strain obtained from marine environment using cultivation techniques with “marine” media, which do not differentiate between facultative marine strains and contaminants from terrestrial habitats.
The aim of this review is to give an overview on secondary metabolites from marine-derived fungi and their biological activities, focusing on the period from 2014 to the present. In similar published reviews, assignments of a given metabolite to a certain category were generally based on structural considerations. It is obvious that classifications of the enormous structural diversity of marine fungal-derived metabolites are different in various literature reports, which only represents the authors’ personal judgments. In this article, these metabolites were classified according to the sources of marine fungi.

2. Metabolites from Marine-Derived Fungi

2.1. Marine Animals

2.1.1. Sponge

Two new 4-hydroxy-2-pyridone alkaloids, arthpyrones (12), were isolated from the fungus Arthrinium arundinis ZSDS1-F3, which obtained from sponge (Xisha Islands, China). Compounds 1 and 2 had significant in vitro cytotoxicities against the K562, A549, Huh-7, H1975, MCF-7, U937, BGC823, HL60, Hela and MOLT-4 cell lines, with IC50 values ranging from 0.24 to 45 μM. Furthermore, compound 2 displayed significant AchE inhibitory activity (IC50 = 0.81 μM), whereas compound 1 showed modest activity (IC50 = 47 μM) (Figure 1) [7].
Chemical examination of the solid culture of the endophytic fungus Stachybotrys chartarum isolated from the sponge Niphates recondita (Weizhou Island in Beibuwan Bay, Guangxi Province of China) resulted in the isolation of seven new phenylspirodrimanes, named chartarlactams (39). Compounds 39 exhibited potent lipid-lowering effects in HepG2 cells in a dose of 10 μM (Figure 2) [8].
The extract of a strain of Aspergillus versicolor MF359 (from the sponge of Hymeniacidon perleve, Bohai Sea, China) yielded one new secondary metabolites, named 5-methoxydihydrosterigmatocystin (10). Compound 10 showed potent activity against Staphylococcus aureus (S. aureus) and Bacillus subtilis (B. subtillis) with MIC values of 12.5 and 3.125 μg/mL, respectively (Figure 3) [9].
The fungus Diaporthaceae sp. PSU-SP2/4 from marine sponge (Trang city, Thailand) generated a new pentacyclic cytochalasin (diaporthalasin, 11). Compound 11 displayed potent antibacterial activity against both S. aureus and methicillin-resistant S. aureus (MRSA) with equal MIC values of 2 μg/mL (Figure 3) [10].
A new chevalone derivative, named chevalone E (12), was isolated from the ethyl acetate extract of the undescribed marine sponge-associated fungus Aspergillus similanensis KUFA 0013, which was collected from the Similan Islands, Phang Nga Province, Southern Thailand. Compound 12 was found to show synergism with the antibiotic oxacillin against methicillin-resistant S. aureus (Figure 3) [11].
Xylarianaphthol-1 (13), a new dinaphthofuran derivative, was isolated from an Indonesian marine sponge-derived fungus of order Xylariales on the guidance of a bioassay using the transfected human osteosarcoma MG63 cells (MG63luc+). Compound 13 activated p21 promoter stably transfected in MG63 cells with dose-dependent pattern. Expression of p21 protein in the wild-type MG63 cells was also promoted by xylarianaphthol-1 treatment, indicating compound 13 was expected to contribute to cancer prevention or treatment (Figure 3) [12].
A new polyketide with a new carbon skeleton, lindgomycin (14), was extracted from mycelia and culture broth of different Lindgomycetaceae strains, which were isolated from a sponge of the Kiel Fjord in the Baltic Sea (Germany) and from the Antarctic. Compound 14 showed antibiotic activities with IC50 value of 5.1 (±0.2) μM against MRSA (Figure 3) [13].

2.1.2. Coral

The fungus Aspergillus terreus SCSGAF0162 was isolated from gorgonian corals Echinogorgia aurantiaca (the South China Sea). Three lactones including three territrem derivatives (1517) and a butyrolactone derivative (18) were isolated from the fungus under solid-state fermentation of rice. Among them, compounds 15 and 16 showed strong inhibitory activity against acetylcholinesterase with IC50 values of 4.2 ± 0.6 and 4.5 ± 0.6 μM, respectively. This was the first report that compounds 17 and 18 had evident antiviral activity towards HSV-1, with IC50 values of 16.4 ± 0.6 and 21.8 ± 0.8 μg·mL–1, respectively. Moreover, compound 15 had obvious antifouling activity with EC50 values of 12.9 ± 0.5 μg·mL–1 toward barnacle Balanus amphitrite larvae (Figure 4) [14].
Two new dihydrothiophene-condensed chromones, oxalicumones (1920) were isolated from a culture broth of the marine gorgonian-associated fungus Penicillium oxalicum SCSGAF 0023. Compounds 19 and 20 showed significant cytotoxicity against several carcinoma cell lines with IC50 less than 10 μM (Figure 5) [15].
The fungal strain Nigrospora oryzae SCSGAF 0111 (from marine gorgonian Verrucella umbraculum, South China Sea) yielded two new citrinins, nigrospins B and C (2122). Compounds 2122 showed weak antifungal activity against Aspergillus versicolor with inhibition zone of 8 cm at 50 μg/paper disc, with a positive control thiram of 8 cm at 5 μg/paper disc (Figure 6) [16].
Two nucleoside derivatives (2324) were isolated from the fungus Aspergillus versicolor which was derived from the gorgonian Dichotella gemmacea in the South China Sea. Compounds 23/24 (a mixture of compound 23:compound 24 at a ratio of 7:10) exhibited selective antibacterial activity against Staphylococcus epidermidis with an MIC value of 12.5 μM (Figure 6) [17].
Two new sulfur-containing benzofuran derivatives, eurothiocin A and B (25 and 26) were isolated from the fungus Eurotium rubrum SH-823 which was obtained from a Sarcophyton sp. soft coral in the South China Sea. The compounds (25 and 26) shared a methyl thiolester moiety, which was quite rare in natural secondary metabolites. Both of them exhibited more potent inhibitory effects against α-glucosidase activity than acarbose, which was the clinical α-glucosidase inhibitor. Further mechanistic analysis demonstrated that both of them exhibited competitive inhibition characteristics (Figure 7) [18].
Chondrostereum sp. was isolated from the inner tissue of a soft coral Sarcophyton tortuosum, which was collected from the Hainan Sanya National Coral Reef Reserve, China. When this fungus was cultured in a liquid medium containing glycerol as the carbon source, a new metabolite, chondrosterin 27 was obtained. Compound 27 exhibited potent cytotoxic activities against the cancer cell lines CNE-1 and CNE-2 with the IC50 values of 1.32 and 0.56 μM (Figure 7) [19].
A steroid derivative, compound 28 was isolated from the fermentation broth of a gorgonian-derived Aspergillus sp. fungus. The fungus was isolated from the inner part of the fresh gorgonian M. abnormalis, which was collected from the Xisha Islands coral reef of the South China Sea. Compound 28 inhibited the larval settlement of barnacle Balanus amphitrite with EC50 18.40 ± 2.0 μg/mL (Figure 7) [20].
A new diphenyl ether derivative, talaromycin A (29) was isolated from a gorgonian-derived fungus, Talaromyces sp. The fungal strain was isolated from a piece of fresh tissue from the inner part of the gorgonian Subergorgia suberosa, collected from the Weizhou coral reef in the South China Sea. Compound 29 showed potent antifouling activities against the larval settlement of the barnacle Balanus amphitrite with the EC50 value 2.8 ± 0.2 μg/mL (Figure 7) [21].

2.1.3. Starfish

Liang et al. [22] investigated the influence on secondary metabolites with variety of cultivation parameters of marine fungus, Neosartorya pseudofischeri, which was isolated from the inner tissue of starfish Acanthaster planci. Glycerol-peptone-yeast extract (GlyPY) and glucose-peptone-yeast extract (GluPY) media were applied to culture this fungus. A novel gliotoxin (30) was produced with GluPY medium. Compound 30 displayed significant inhibitory activities against three multidrug-resistant bacteria, S. aureus (ATCC29213), MRSA (R3708) and Escherichia coli (E. coli) (ATCC25922), as well as cytotoxicities against some cell lines including human embryonic kidney (HEK) 293 cell line and human colon cancer cell lines, HCT-116 and RKO (a poorly differentiated colon carcinoma cell line) (Figure 8).
A novel isobenzofuranone derivative, pseudaboydins A (31) was isolated from the marine fungus, Pseudallescheria boydii, associated with the starfish, Acanthaster planci. Compound 31 showed moderate cytotoxic activity against HONE1, SUNE1 and GLC82 with IC50 values of 37.1, 46.5 and 87.2 μM, respectively (Figure 8) [23].

2.1.4. Bryozoan

Three new cyclohexadepsipeptides of the isaridin class including isaridin G (32), desmethylisaridin G (33), and desmethylisaridin C1 (34) were isolated and identified from the marine bryozoan-derived fungus Beauveria felina EN-135. Compounds 3234 showed inhibitory activity against E.coli with MIC values of 64, 64, and 8 μg/mL, repectively. This is the first report on antibacterial activities of the isaridins (Figure 9) [24].
Bioassay-guided fractionation of a culture extract of Beauveria felina EN-135, an entomopathogenic fungus isolated from an unidentified marine bryozoan, led to the isolation of a new cyclodepsipeptide, iso-isariin D (35); two new O-containing heterocyclic compounds felinones A and B (36 and 37). Compound 35 exhibited potent lethality against brine shrimp (Artemia salina), with LD50 values of 26.58 μΜ, notably stronger than that of the positive control colchicine, while compounds 36 and 37 possessed weak activity. Only compound 37 showed inhibitory activity (MIC value of 32 μg/mL) higher than that of the chloramphenicol control (MIC value of 4 μg/mL) against Pseudomonas aeruginosa (Figure 9) [25].

2.1.5. Sea Urchin

The Penicillium sp. SF-6013 was isolated from the sea urchin Brisaster latifrons, which was collected from the Sea of Okhotsk. Chemical investigation of strain SF-6013 resulted in the discovery of a new tanzawaic acid derivative, 2E,4Z-tanzawaic acid D (38). Screening for anti-inflammatory effects in lipopolysaccharide (LPS)-activated microglial BV-2 cells indicated that compound 38 inhibited the production of nitric oxide (NO) with IC50 values of 37.8 μM (Figure 10) [26].

2.1.6. Fish

Two new rubrolides, rubrolides R (39) and S (40), were isolated from the fermentation broth of the marine-derived fungus Aspergillus terreus OUCMDZ-1925, which was isolated from the viscera of C. haematocheilus grown in the waters of the Yellow River Delta. Compound 39 showed comparable or superior antioxidation against ABTS radicals to those of trolox and ascorbic acid with an IC50 value of 1.33 μM. Compound 40 showed comparable or superior anti-influenza A (H1N1) virus activity to that of ribavirin with an IC50 value of 87.1 μM. Compounds 39 and 40 showed weak cytotoxicity against the K562 cell line with IC50 values of 12.8 and 10.9 μM, respectively, while were inactive against the A549, HL-60, Hela and HCT-116 cell lines (Figure 10) [27].

2.1.7. Prawn

The fungal strain, Aspergillus flavus OUCMDZ-2205, was obtained from the prawn, Penaeus vannamei, from the Lianyungang sea area, Jiangsu Province of China. Two new indole-diterpenoids (41 and 42) were isolated from the fermentation broth of the fungus. Compound 41 exhibited antibacterial activity against S. aureus with a MIC value of 20.5 μM and showed PKC-beta inhibition with an IC50 value of 15.6 μM. Both 41 and 42 could arrest the A549 cell cycle in the S phase at a concentration of 10 μM (Figure 11) [28].

2.1.8. Others

The marine-derived fungus Eurotium amstelodami was isolated from an unidentified marine animal collected from the Sungsan coast in Jeju Island, Korea. An anthraquinone derivative, questinol (43) was successfully isolated from the broth extract of the fungus for the first time. Questinol (43) did not exhibit cytotoxicity in LPS-stimulated RAW 264.7 cells up to 200 μM while could significantly inhibit NO and PGE2 production at indicated concentrations. Furthermore, it could inhibit the production of pro-inflammatory cytokines, including IL-1β, TNF-α, and IL-6 and suppress the expression level of iNOS in a dose-dependent manner through the western blot analysis. All these results suggest that questinol might be selected as a promising agent for the prevention and therapy of inflammatory disease (Figure 11) [29].
A novel aspochalasin, 20-β-methylthio-aspochalsin Q (named as aspochalasin V, 44) was isolated from culture broth of Aspergillus sp., which was obtained in the gut of a marine isopod Ligia oceanica (Dinghai in Zhoushan, Zhejiang Province of China). This is the first report about methylthio-substituted aspochalasin derivative. Apochalasin V showed moderate cytotoxic activity against the prostate cancer PC3 cell line and HCT116 cell line with IC50 values of 30.4 and 39.2 μM, respectively (Figure 11) [30].
Two new cerebrosides, penicillosides A (45) and B (46) were isolated from the marine-derived fungus Penicillium species, which were gained from the Red Sea tunicate, Didemnum species in the Mangrove. Penicilloside A displayed antifungal activity against Candida albicans while penicilloside B illustrated antibacterial activities against S. aureus and E. coli. Additionally, both compounds showed weak activity against HeLa cells (Figure 11) [31].

2.2. Mangrove

Six new compounds with polyketide decalin ring, peaurantiogriseols A–F (4752), were isolated from the fermentation products of mangrove endophytic fungus Penicillium aurantiogriseum328#, which was collected from the bark of Hibiscus tiliaceus in the Qi’ao Mangrove Nature Reserve of Guangdong Province, China. Compounds 4752, showed low inhibitory activity against human aldose reductase (at a concentration of 50 µM), the corresponding value of percent inhibitions were 16%, 6%, 31%, 22%, 26%, 2%, respectively (Figure 12) [32].
Aspergifuranone (53), isocoumarin derivatives (±) 54 were separated from the mangrove endophytic fungus Aspergillus sp. 16-5B, which was isolated from the leaves of Sonneratia apetala from Dongzhaigang Mangrove National Nature Reserve in Hainan Island, China. Both of them were evaluated for their α-glucosidase inhibitory activities, and compound 53 showed significant inhibitory activity with IC50 value of 9.05 ± 0.60 μM. Kinetic analysis showed that compound 53 was a noncompetitive inhibitor of α-glucosidase. Compound 54 exhibited moderate inhibitory activities, with IC50 value of 90.4 ± 2.9 μM (Figure 13) [33].
A new alkaloid, brocaeloid B (55), containing C-2 reversed prenylation, was isolated from cultures of Penicillium brocae MA-192, an endophytic fungus obtained from the fresh leaves of the marine mangrove plant Avicennia marina in Hainan island, China. Compound 55 showed lethality against brine shrimp (Artemia salina) with an LD50 value of 36.7 μM (Figure 13) [34].
The fungus Phoma sp. OUCMDZ-1847, which was isolated from a mangrove fruit sample of Kandelia candel (Wenchang, Hainan Province, China), generated a new thiodiketopiperazine, named phomazines B (56). Compound 56 showed cytotoxicity against the MGC-803 cell line with IC50 value of 8.5 μM (Figure 13) [35].
Four new disulfide-bridged diketopiperazine derivatives, brocazines (5760) were isolated from Penicillium brocae MA-231, a fungus obtained from the fresh tissue of the marine mangrove plant Avicennia marina that was collected at Hainan Island, China. Compounds 5760 showed cytotoxic activities against nine tumor cell lines, including Du145, HepG2, HeLa, NCI-H460, MCF-7, SGC-7901, SW1990, U251 and SW480, with IC50 values ranging from 0.89 to 9.0 μM (Figure 13) [36].
A new isochroman, (3R,4S)-3,4-dihydro-8-hydroxy-4-methoxy-3-methylisocoumarin (61), was isolated from the marine fungus Phomopsis sp. (No. Gx-4), which was obtained from the mangrove sediment of ZhuHai, Guangdong, China. Primary bioassays and preliminary pharmacological tests indicated that compound 61 could accelerate the growth of subintestinal vessel plexus (SIV) branches markedly (Figure 14) [37].
Penicillium brocae MA-231, an endophytic fungus, was obtained from the fresh tissue of the marine mangrove plant Avicennia marina. After investigation, five new sulfide diketopiperazine derivatives, namely, penicibrocazines A–E (6266) were isolated and identified. In the antimicrobial experiments, compounds 6365 showed activity against S. aureus, with MIC values of 32.0, 0.25 and 8.0 μg/mL, respectively. Compound 64 also showed activity against Micrococcus luteus with MIC value of 0.25 μg/mL. Moreover, compounds 63, 65 and 66 implied activity against plant pathogen Gaeumannomyces graminis with MIC values of 0.25, 8.0, and 0.25 μg/mL, respectively (Figure 14) [38].
Two new biogenetically related compounds (6768) have been isolated from a fungus Penicillium dipodomyicola HN4-3A from mangrove of South China Sea. Compounds 67 and 68 showed strong inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) with IC50 values of 0.16 ± 0.02 μM and 1.37 ± 0.05 μM, respectively (Figure 15) [39].
Investigation of the marine mangrove-derived fungal strain Penicillium sp. MA-37 resulted in the isolation of one new benzophenone, iso-monodictyphenone (69) and two new diphenyl ether derivatives penikellides A (70) and B (71). Compounds 6971 exhibited brine shrimp lethality, with LD50 values of 25.3, 14.2 and 39.2 μM, respectively, while the positive control colchicine had LD50 value of 1.22 μM. Compound 69 showed antibacterial activity against Aeromonas hydrophilia with MIC 8 μg/mL, while the positive control, chloromycetin exhibited a MIC of 4 μg/mL (Figure 15) [40].
A new naphthalene derivative, vaccinal A (72), was isolated from Pestalotiopsis vaccinii (cgmcc3.9199) endogenous with the mangrove plant Kandelia candel (L.) Druce (Rhizophoraceae). Compound 72 exhibited in vitro anti-enterovirus 71 (EV71) with IC50 value of 19.2 μM and potent COX-2 inhibitory activity with IC50 value of 1.8 μM (Figure 16) [41].
The fungus Astrocystis sp. BCC 22166 was isolated from a mangrove palm, Nypa, at Hat Khanom-Mu Ko Thale Tai National Park, Nakhon Si Thammarat Province of Thailand. Two new compounds, phthalide 73, dihydroisocoumarin 74 were separated from the fungus. Compound 73 exhibited antibacterial activity against Bacillus cereus (IC50 = 12.5 μg/mL), while compound 74 showed cytotoxicity to KB and Vero cells with values of IC50 22.6 and 48.2 μg/mL respectively (Figure 16) [42].
A new aromatic amine, pestalamine A (75) was isolated from mangrove-derived endophytic fungus Pestalotiopsis vaccinii that was isolated from a branch of Kandelia candel (L.) Druce (Rhizophoraceae), a usual viviparous mangrove species in coastal and estuarine areas of southern China. Pestalamine A (75) showed moderate cytotoxicities against human cancer cell lines (MCF-7, HeLa, and HepG2) with IC50 values of 40.3, 22.0, and 32.8 μM, respectively (Figure 16) [43].
A new aromatic butyrolactone, flavipesins A (76), was isolated from marine-derived endophytic fungus Aspergillus flavipes. AIL8. This was isolated from the inner leaves of mangrove plant Acanthus ilicifolius (Daya Bay, Shenzhen City, Guangdong Province, China). Compound 76 displayed significant antibacterial activity against S. aureus (MIC = 8.0 μg/mL) and B. subtillis (MIC = 0.25 μg/mL). Compound 76 also showed the unique antibiofilm activity of decreasing the number of living cells embed in the biofilm matrix from 390.6 to 97.7 μg/mL (p < 0.01). This indicates that compound 76 could penetrate the biofilm matrix and kill the living bacteria inside mature S. aureus biofilm (Figure 17) [44].
A new prenylated phenol vaccinol I (77) was isolated from endogenous fungi Pestalotiopsis vaccinii (cgmcc3.9199) of mangrove plant Kandelia candel (L.) Druce (Rhizophoraceae). Compound 77 exhibited potent COX-2 inhibitory activity (IC50 = 16.8 μM) (Figure 17) [45].
Penicibilaenes A (78) and B (79), two sesquiterpenes possessing a tricyclo[6.3.1.01,5] dodecane skeleton, were characterized from Penicillium bilaiae MA-267, a fungus obtained from the rhizospheric soil of the mangrove plant Lumnitzera racemosa. Both of them exhibited selective activity against the plant pathogenic fungus Colletotrichum gloeosporioides (MIC = 1.0 and 0.125 μg/mL, respectively) (Figure 17) [46].
Three new resveratrol derivatives, resveratrodehydes A–C (8082), were isolated from the mangrove endophytic fungus Alternaria sp. R6. All compounds showed broad-spectrum inhibitory activities against human breast MDA-MB-435, human liver HepG2, and human colon HCT-116 by MTT assay (IC50 < 50 μM). Especially, compounds 80 and 81 both exhibited marked cytotoxic activities against HCT-116 and MDA-MB-435 cell lines (IC50 < 10 μM). Additionally, compounds 80 and 82 showed moderate antioxidant effect by DPPH radical scavenging assay (Figure 17) [47].
The strategy that co-cultivation of two mangrove fungi, Phomopsis sp. K38 and Alternaria sp. E33 (Leizhou Peninsula, Guangdong Province, China) in a single confined environment generated new active natural products, including three new cyclic tetrapeptides, cyclo(d-Pro-l-Tyr-l-Pro-l-Tyr) (83), cyclo(Gly-l-Phe-l-Pro-l-Tyr) (84) and cyclo(l-leucyl-trans-4-hydroxy-l-prolyl-d-leucyl-trans-4-hydroxy-l-proline) (85). Compounds 8385 showed moderate to high antifungal activities (Candida albicans, Gaeumannomyces graminis, Rhzioctonia cerealis, Helminthosporium sativum and Fusarium graminearum) as compared with the positive control (Figure 18) [48,49].

2.3. Sediment

Penicillium chrysogenum PJX-17, which was separated from marine sediment (South China Sea) generated two novel sorbicillinoids combining a bicyclo[2.2.2] octane with a 2-methoxyphenol moiety, sorbicatechols A (86) and B (87) respectively. Compounds 86 and 87 exhibited activities against influenza virus A (H1N1), with IC50 values of 85 and 113 μM, respectively (Figure 19) [50].
The fungal strain Penicillium sp. F446, which was isolated from marine sediments at the depth of 25 m collected from Geomun-do (Island), Korea, generated a novel meroterpenoid, penicillipyrones B (88). Compound 88 showed significant induction of quinone reductase (Figure 19) [51].
An epidithiodiketopiperazine, N-methyl-pretrichodermamide B (89) was isolated from the fungus Penicillium sp. WN-11-1-3-1-2, derived from the sediment of a hyper saline lake located at Wadi El-Natrun in Egypt, 80 km northwest of Cairo. Compound 89 showed pronounced cytotoxicity against the murine lymphoma L5178Y mouse lymphoma cell line, IC50 = 2 μM (Figure 20) [52].
One new polyketide (90) was isolated from the lipophilic extract of the marine-derived fungus Isaria felina KMM 4639 from marine sediments at a depth of 10 m (South China Sea, coast of Vietnam). Compound 90 exhibited cytotoxicity against HL-60 and THP-1 cell lines with IC50 values of 4.3 and 37.4 μM, respectively (Figure 20) [53].
One new indolediketopiperazine peroxide, 13-O-prenyl-26-hydroxyverruculogen (91), was isolated and identified from the culture extract of the marine sediment-derived fungus Penicillium brefeldianum SD-273. Compound 91 showed potent lethality against brine shrimp (Artemia salina), with LD50 value of 9.44 μΜ, comparing with the positive control colchicine (LD50 = 99.0 μΜ) (Figure 20) [54].
Fungus Spicaria elegans KLA03 was derived from marine sediments collected in Jiaozhou Bay, China. Eleganketal A (92), a naturally occurring aromatic polyketide possessing a rare highly oxygenated spiro[isobenzofuran-1,3′-isochroman] ring system, was isolated from the fungus by culturing it in a modified mannitol-based medium. The synthetic (±)-92a and its separated enantiomers showed no cytotoxicity against HL-60 and K562 cells (IC50 > 50 μM). Only compound (−)-92a exhibited activity against the influenza A H1N1 virus with an IC50 = 149 μM (Figure 21) [55].
Two novel tetracyclic oxindole alkaloids, speradines G (93) and H (94), were isolated from the marine-derived fungus Aspergillus oryzae, isolated from marine sediments (Langqi Island, Fujian, China). This is the first report on cyclopiazonic acid (CPA)-type alkaloids with a hexacyclic skeleton. The compounds 9394 showed unconspicuous cytotoxic effects on the Hela, HL-60 and K562 cell lines, IC50 values larger than 30 μg/mL (Figure 21) [56].
One new cyclic peptide, psychrophilins (95), possessing a rare amide linkage between the carboxylic acid in anthranilic acid (ATA) and the nitrogen from an indole moiety, was obtained from the culture of the marine-derived fungus Aspergillus versicolor ZLN-60, isolated from the mud (depth, 20 m) of the Yellow Sea. Compound 95 showed potent lipid-lowering effects at a dose of 10 μM as assessed by Oil Red O staining (Figure 22) [57].
Two new prenylated indole alkaloids, including a β-carboline, penipalines B (96), and one indole carbaldehyde derivative, penipaline C (97), were obtained from the deep-sea-sediment derived fungus Penicillium paneum SD-44 cultured in a 500-L bioreactor. Compounds 96 and 97 showed potent cytotoxic activities against two tumor cell lines, A-549 and HCT-116. The IC50 values of compounds 96 and 97 against HCT-116 were 14.88 and 18.54 μM, while those against A-549 were 20.44 and 21.54 μM, respectively (Figure 22) [58].
The fungal strain Aspergillus versicolor HDN08-60, isolated from the sediments in the South China Sea, was fermented on liquid culture (60 L) for 30 days and extracted three times with EtOAc. A novel versicamide H (98) was obtained. Compound 98 exhibited moderate activity against HL-60 cells (IC50 = 8.7 μM) and selective PTK inhibitory activities in further investigation with target screening (Figure 22) [59].
After modified diethyl sulphate mutagenesis procedure, a marine-derived fungus Penicillium purpurogenum G59 (the tideland of Bohai Bay, Tianjin, China) yielded four new antitumor compounds named penicimutanolone (99), penicimutanin A (100), penicimutanin B (101), and penicimutatin (102). Compounds 99101 inhibited several human cancer cell lines (K562, HL-60, HeLa, BGC-823, and MCF-7) with IC50 values lower than 20 μM, compound 102 also inhibited the cell lines to some extent [60]. In addition, three new C25 steroids (103105) with an unusual bicyclo[4.4.1]A/B ring with the Z-configuration of 20,22-double bond were isolated. All of them weakly inhibited several human cancer cell lines (K562, HL-60 and HeLa) to varying extents (Figure 23) [61]. Furthermore, seven new (106112) lipopeptides were isolated from the extract of mutant, which showed weak cytotoxicity (Figure 23) [62]. These results provided the way to discover new compounds by activating silent fungal metabolic pathways.
Ascotricha sp. ZJ-M-5, is a fungus isolated from a mud sample, which was collected on a coastal beach in Fenghua County, Zhejiang Province, China. Chemical investigations were found to produce cyclonerodiol analogues, a 3,4-seco lanostane triterpenoid, and diketopiperazines in an eutrophic medium by the one strain-many compounds (OSMAC) analysis. Two new caryophyllene derivatives (113114) were produced in an oligotrophic medium, Czapek Dox broth with or without Mg2+. (+)-6-O-Demethylpestalotiopsin A (113) and (+)-6-O-demethylpestalotiopsin C (114), which have a five-membered hemiacetal structural moiety, showed growth inhibitory abilities against K562 and HL-60 leukemia cell lines with the lowest GI50 value of 6.9 ± 0.4 μM. This indicated that modification of the culture media was effective in the discovery of novel bioactive fungal secondary metabolites (Figure 24) [63].
The marine fungus Cladosporium sp. was isolated from a sediment sample collected from Yangshashan Bay, Ningbo, Zhejiang Province, China. Two new sulfur-containing diketopiperazines (DKPs), cladosporin A (115) and cladosporin B (116), were separated from the fungus by high-speed counter-current chromatography (HSCCC). Cytotoxic activity tests showed that compounds 115 and 116 exhibited moderate cytotoxic activities to HepG2 cell line, with values of IC50 21 and 42 μg/mL (Figure 24) [64].
A novel cyclic dipeptide, 14-hydroxy-cyclopeptine (117), was purified from a deep sea derived fungus SCSIOW2 identified as an Aspergillus sp. Fungus SCSIOW2 was isolated from deep marine sediment sample collected in the South China Sea at a depth of 2439 m. Compound 117 inhibited nitric oxide production with IC50 value at 40.3 μg/mL in a lipopolysaccharide and recombinant mouse interferon-γ-activated macrophage-like cell line, RAW 264.7 (Figure 25) [65].
Trichobotrysins (118120), a class of new tetramic acid derivatives with a decalin ring, were characterized from the culture of Trichobotrys effuse DFFSCS021 derived from the deep sea sediment collected from the South China Sea. Compounds 118120 exhibited significant selective cytotoxicity against human carcinoma KG-1a cell line with IC50 values of 5.44, 8.97, and 6.16 μM, and obvious antiviral activity towards HSV-1 with IC50 values of 3.08, 9.37, and 3.12 μM, respectively (Figure 25) [66].

2.4. Alga

The Aspergillus ustus cf-42 strain, which was obtained from the fresh tissue of the marine green alga C. fragile (Zhoushan Island, China), generated a new ergosteroid derivative, isocyathisterol (121). Compound 121 exhibited weak antibacterial activity against S. aureus and E. coli (inhibitory diameters of 5.7 and 6.7 mm, respectively) at 30 mg/disc (Figure 26) [67].
Five new polyketides (122126) have been isolated from the lipophilic extracts of the marine-derived fungi Penicillium thomii and Penicillium lividum isolated from superficial mycobiota of the brown alga Sargassum miyabei (Lazurnaya Bay, the Sea of Japan). Compound 123 was able to inhibit the transcriptional activity of the oncogenic nuclear factor AP-1 with IC50 value of 15 μM after 12 h of treatment. Compound 125 exhibited cytotoxicity against splenocytes with a IC50 value of 38 μM. It was shown that compounds 124 and 126 at a non-toxic concentration (10 μM) inhibited the adhesion of macrophages (30%–40% of inhibition). In addition, compounds 122 and 125 exhibited radical scavenging activity against DPPH with IC50 values of 100 and 50 μM, respectively (Figure 26) [68].
Seven new austalide meroterpenoids (127133) were isolated from the alga-derived fungi Penicillium thomii KMM 4645 and Penicillium lividum KMM 4663, which was isolated from superficial mycobiota of the brown alga Sargassum miyabei (Lazurnaya Bay, the Sea of Japan). Compounds 127, 128, 132 and 133 could inhibit AP-1-dependent transcriptional activity in JB6 Cl41 cell lines at noncytotoxic concentrations. Compounds 127133 exhibited significant inhibitory effects against endo-1,3-β-d-glucanase from a crystalline stalk of the marine mollusk Pseudocardium sachalinensis (Figure 27) [69].
The fungal strain Penicillium echinulatum pt-4 was isolated from marine red alga Chondrus ocellatus that was collected from the coast of Pingtan Island, China. One new meroterpene, arisugacin K (134) was isolated from the culture of strain pt-4. Compound 134 showed inhibitory activity against E. coli with an inhibition diameter 8 mm at 30 μg/disk (Figure 28) [70].
A new nitrobenzoyl sesquiterpenoid, 6b,9a-dihydroxy-14-p-nitrobenzoylcinnamolide (135) was isolated from extracts of the culture of marine-derived fungus Aspergillus ochraceus Jcma1F17, which was derived from a marine alga Coelarthrum sp. in Paracel Islands, South China Sea. Compound 135 displayed significant cytotoxicities against 10 cancer cell lines (K562, H1975, U937, Molt-4, BGC-823, HL60, MCF-7, A549, Hela, and Huh-7), with IC50 values of 1.95 μM to 6.35 μM. In addition, compound 135 also showed antiviral activities against EV71 and H3N2 (Figure 28) [71].
A structurally unique 3H-oxepine-containing alkaloid, varioxepine A (136), characterized by a condensed 3,6,8-trioxabicyclo[3.2.1]octane motif, was isolated from the marine algal-derived endophytic fungus Paecilomyces variotii. Compound 136 was evaluated for antimicrobial activity against several human- and aqua-pathogenic bacteria (Aeromonas hydrophila, S. aureus, Vibrio anguillarum, E. coli, Micrococcus luteus, Vibrio harveyi, and Vibrio parahemolyticus). The results revealed that compound 136 has diverse antibacterial activities with the MIC values ranging from 16 to 64 μg/mL. Furthermore, it inhibited plant pathogenic fungus Fusarium graminearum, with an MIC value of 4 μg/mL (Figure 28) [72].
Two new butenolides, namely, butyrolactone IX (137) and aspulvinone O (138) were isolated from the marine-derived endophytic fungus Paecilomyces variotii from Grateloupia turuturu, a red alga collected from the coast of Qingdao, China. The isolated butenolides were tested for the activity against DPPH radicals and the results indicated that butyrolactone (137) possessed potent activity with IC50 values 186.3 μM, while aspulvinone (138) showed significant activity with IC50 value 11.6 μM. The author speculated that a larger conjugated aromatic system gave aspulvinone (138) more stronger DPPH radical scavenging activity than that of butyrolactone (137) (Figure 29) [73].
A new benzamide derivative (methyl 4-(3,4-dihydroxybenzamido) butanoate (139) was isolated from themarine brown alga-derived endophytic fungus Aspergillus wentii EN-48. Compound 139 showed significant scavenging activity against DPPH with IC50 values of 5.2 μg/mL, which was significantly stronger than BHT (IC50 = 36.9 μg/mL) (Figure 29) [74].
Two new oxepine-containing diketopiperazine-type alkaloids, varioloids A and B (140 and 141), were isolated from the fungus Paecilomyces variotii EN-291, which was isolated from Grateloupia turuturu, a marine red algae collected from the coast of Qingdao, China. Compounds 140 and 141 exhibited potent activity against the plantpathogenic fungus Fusarium graminearum with MIC values of 8 and 4 μg/mL, respectively (Figure 30) [75].
A new eudesmane sesquiterpenoid, eudesma-4(15),7-diene-5,11-diol (142) has been isolated from the red alga Laurencia obtusa, which was collected off the Saudi Arabia Red Sea Coast at Jeddah. Both qualitative and quantitative antifungal assays revealed that compound 142 exhibited a good antifungal effect against Candida albicans, Candida tropicals, Aspergillus flavus and Aspergillus niger; the MIC values were 2.92, 2.10, 2.92, 6.5 μg/mL, respectively (Figure 30) [76].

2.5. Sea Water

One unusual pyridone, trichodin A (143), was extracted from the marine fungus, Trichoderma sp. strain MF106 isolated from the Greenland Seas. Compound 143 showed antibiotic activities against Staphylococcus epidermidis with IC50 value of 24 μM (Figure 31) [77].
The fungus Penicillium 303# was isolated from sea water, which was collected from Zhanjiang Mangrove National Nature Reserve in Guangdong Province, China. Three new metabolites (compounds 144146) were isolated from the fungus fermentation medium. Those compounds showed weak to moderate cytotoxic activities against MDA-MB-435 (Figure 31) [78].
A marine strain Stachybotrys sp. MF347, which was isolated from a driftwood sample collected at Helgoland (North Sea, Germany), provided a novel spirocyclic drimane coupled by two drimane fragment building blocks 147. Compound 147 exhibited comparable antibacterial activities with chloramphenicol against the clinically relevant MRSA (Figure 32) [79].
Penicilliumine (148), a new structure was isolated from the fermentation Penicillium commune 366606, a marine-derived fungus isolated from the sea water collected at Qingdao, China. Compound 148 was not cytotoxic against MCF-7, SMMC-7721, HL-60, A-549 and SW480 cells or no potent inhibiting the nitric oxide release. Compound (−)-148 and (+)-148 could inhibit the acetylcholinesterase activity by 18.7% (±0.26%) and 32.4% (±2.08%) at the concentration of 50 μM, respectively, compared with 43.6% (±2.12%) inhibition rate of the positive control tacrine (Figure 32) [80].
A strain of the fungus Penicillium chrysogenum was collected from sea water (10–25 m depth), off the North Sea coast, China. A new benzoic acid, 2-(2-hydroxypropanamido) benzoic acid (149), isolated from the fermentation broth of fungus, showed remarkable anti-inflammatory and analgesic activities but exhibited no ulcerogenic effect (Figure 32) [81].

2.6. Others

Racemic dinaphthalenone derivatives (±)-asperlone A (150) and (±)-asperlone B (151) were isolated from the cultures of Aspergillus sp. 16-5C from the leaves of S. apetala, which were collected in Hainan Island, China. Compounds 150 and 151 exhibited potent inhibitory effects against Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) with IC50 values of 4.24 ± 0.41, 4.32 ± 0.60 μM, respectively, which represent a new type of lead compounds for the development of new anti-tuberculosis drugs (Figure 33) [82].
A new polychlorinated triphenyl diether named microsphaerol (152) and a new naphthalene derivative named seimatorone (153), were isolated from the endophtic fungus Microsphaeropsis sp. and Seimatosporium sp., which were isolated from the halotolerant herbaceous plant Salsola oppositifolia from Playa del Ingles (Gomera, Spain). Preliminary studies revealed that compound 152 showed good antibacterial activities against Bacillus Megaterium and E. coli, and good antilagal and antifungal activities against Chlorella fusca and Microbotryum violaceum, respectively. On the other hand, compound 153 exhibited moderate antibacterial, antialgal, and antifungal activities (Figure 33) [83].

3. Future Perspectives and Concluding Remarks

Based on the above literature, we can find that marine-derived Aspergillus and Penicillium are the most ubiquitous genera, probably because both of them are salt tolerant, fast growing and easily obtained. As seen in Figure 34, about 3/4 of all new compounds reported from marine fungi are derived from isolation from living matter, i.e. marine animals (30.1%) and marine plants (42.5%), while the remaining compounds are obtained from non-living sources, most notably sediments (22.9%). Within the individual groups, mangrove habitats (25.5%), alga (14.4%), and sponges (9.2%) are the predominant sources for fungal diversity. A newly emerging source is the deep sea. The extreme environment encountered in the form of low temperature, elevated hydrostatic pressure, absence of light, high concentrations of metals in hydrothermal vents and hypoxic conditions possibly produce structurally unique metabolites. Nevertheless, very few reports are related to this habitat because of scarcity of source. It is worth mentioning that an increasing number of Chinese scientists are engaging in this research field, mostly focusing on mangrove areas around South China Sea.
According to the structural types, of the 153 compounds included in this review, alkaloids (27.0%) and polyketides (25.7%) play a dominant role. Moreover, peptides, terpenes, lactone, and steroids are 13.8%, 9.9%, 3.9% and 3.3%, respectively (see Figure 35).
As illustrated in Figure 36, biological activities of these compounds are mainly focused in the areas of cytotoxicity (37.5%) and antimicrobial activity, including antibacterial activity (18.4%), antifungal activity (7.9%) and antiviral activity (7.2%). Furthermore, other selective activities include antioxidant, anti-inflammatory, antifouling, lipid-lowering activities, lethality against brine shrimp effects, etc.
The oceans are the largest underexploited wealthy resource of potential drugs. Marine-derived fungi have provided a variety of potential pharmacological metabolites and thus represent a valuable resource of new drug candidates. In the period covered by the first review of this series, from the beginning until 2002, 272 new structures had been reported, in 2009 more than 200 was reached [2], and in 2012 and 2013, the numbers were 288 and 302, respectively [3,84]. Though bioactivities of secondary metabolites from marine fungi reveal interesting levels for a number of clinical relevant targets, they are not well represented in the pipelines of drugs and none of them currently is on the market. Only Plinabulin, a synthetic cyclic dipeptide analogue of halimide, which is isolated from a marine fungus species, is in phase II clinical trial for treatment of non-small cell lung cancer. Thus, there is still a long way to go [85].
First of all, many marine-derived fungal biosynthetic pathways are silent under common laboratory culture conditions, and activation of the silent pathways may enable access to new metabolites. One strain–many compounds (OSMAC) strategy, chemical epigenetic modification (e.g., using DNA methyltransferase inhibitor, 5-azacytidine, histone deacetylase inhibitors, suberoylanilide hydroxamic acid and sodium butyrate [60,61,62,86,87,88]), co-culture method [48], or gene level manipulations could be applied to access new secondary metabolites. Furthermore, as mentioned above, alterations of the culture conditions might lead to changes of the metabolic spectrum. The pharmaceutical industry should concentrate on how to appropriately maintain certain physico-chemical factors, viz., amount of oxygen available, optimum pH and temperature, avoiding variation of secondary metabolites.
What is more, a better understanding of the molecular basis of biosynthesis and regulation mechanisms will contribute to making better use of the enormous chemical potential of marine derived fungi, which depends on the continuous development of the new techniques [89,90].
In addition, beyond the current in vitro bioactivity examination, further in vivo and preclinical studies, as well as side effects examinations, are required to determine the bioactive compounds with potential therapeutic applications.
We believe that with the development of more automated and more affordable techniques for isolating and characterizing marine fungi bioactive metabolites, marine fungi will be promising sources for novel therapeutic agents that will be useful in controlling human diseases and protecting human health.

Acknowledgments

This work was financially supported by National Natural Science Foundation of China (NO.21272031 and NO.21372037) and Fundamental Research Fund for the Central Universities (DC201501020302, DC201502020201 and DC201501081).

Author Contributions

All authors contributed as the same for the manuscript preparation and design.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schueffler, A.; Anke, T. Fungal natural products in research and development. Nat. Prod. Rep. 2014, 31, 1425–1448. [Google Scholar] [CrossRef] [PubMed]
  2. Rateb, M.E.; Ebel, R. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 2011, 28, 290–344. [Google Scholar] [CrossRef] [PubMed]
  3. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2015, 32, 116–211. [Google Scholar] [CrossRef] [PubMed]
  4. Hamilton-Miller, J.M.T. Development of the semi-synthetic penicillins and cephalosporins. Int. J. Antimicrob. Agents 2008, 31, 189–192. [Google Scholar] [CrossRef] [PubMed]
  5. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196–268. [Google Scholar] [CrossRef] [PubMed]
  6. Kohlmeyer, J.; Kohlmeyer, E. Marine Mycology: The Higher Fungi; Academic Press: New York, NY, USA, 1979; pp. 704–705. [Google Scholar]
  7. Wang, J.; Wei, X.; Qin, X.; Lin, X.; Zhou, X.; Liao, S.; Yang, B.; Liu, J.; Tu, C.; Liu, H. Arthpyrones A–C, pyridone alkaloids from a sponge-derived fungus Arthrinium arundinis ZSDS1-F3. Org. Lett. 2015, 17, 656–659. [Google Scholar] [CrossRef] [PubMed]
  8. Li, Y.; Wu, C.; Liu, D.; Proksch, P.; Guo, P.; Lin, W.H. Chartarlactams A–P, phenylspirodrimanes from the sponge-associated fungus Stachybotrys chartarum with antihyperlipidemic activities. J. Nat. Prod. 2014, 77, 138–147. [Google Scholar] [CrossRef] [PubMed]
  9. Song, F.; Ren, B.; Chen, C.; Yu, K.; Liu, X.; Zhang, Y.; Yang, N.; He, H.; Liu, X.; Dai, H.; Zhang, L. Three new sterigmatocystin analogues from marine-derived fungus Aspergillus versicolor MF359. Appl. Microbiol. Biotechnol. 2014, 98, 3753–3758. [Google Scholar] [CrossRef] [PubMed]
  10. Khamthong, N.; Rukachaisirikul, V.; Phongpaichit, S.; Preedanon, S.; Sakayaroj, J. An antibacterial cytochalasin derivative from the marine-derived fungus Diaporthaceae sp. PSU-SP2/4. Phytochem. Lett. 2014, 10, 5–9. [Google Scholar] [CrossRef]
  11. Prompanya, C.; Dethoup, T.; Bessa, L.J.; Pinto, M.M.M.; Gales, L.; Costa, P.M.; Silva, A.M.S.; Kijjoa, A. New isocoumarin derivatives and meroterpenoids from the marine sponge-associated fungus Aspergillus similanensis sp. Nov. KUFA 0013. Mar. Drugs 2014, 12, 5160–5173. [Google Scholar] [CrossRef] [PubMed]
  12. Kotoku, N.; Higashimoto, K.; Kurioka, M.; Arai, M.; Fukuda, A.; Sumii, Y.; Sowa, Y.; Sakai, T.; Kobayashi, M. Xylarianaphthol-1, a novel dinaphthofuran derivative, activates p21 promoter in a p53-independent manner. Bioorg. Med. Chem. Lett. 2014, 24, 3389–3391. [Google Scholar] [CrossRef] [PubMed]
  13. Wu, B.; Wiese, J.; Labes, A.; Kramer, A.; Schmaljohann, R.; Imhoff, J.F. Lindgomycin, an unusual antibiotic polyketide from a marine fungus of the Lindgomycetaceae. Mar. Drugs 2015, 13, 4617–4632. [Google Scholar] [CrossRef] [PubMed]
  14. Nong, X.; Wang, Y.; Zhang, X.; Zhou, M.; Xu, X.; Qi, S. Territrem and butyrolactone derivatives from a marine-derived fungus Aspergillus terreus. Mar. Drugs 2014, 12, 6113–6124. [Google Scholar] [CrossRef] [PubMed]
  15. Bao, J.; Luo, J.; Qin, X.; Xu, X.; Zhang, X.; Tu, Z.; Qi, S. Dihydrothiophene-condensed chromones from a marine-derived fungus Penicillium oxalicum and their structure-bioactivity relationship. Bioorg. Med. Chem. Lett. 2014, 24, 2433–2436. [Google Scholar] [CrossRef] [PubMed]
  16. Dong, J.; Bao, J.; Zhang, X.; Xu, X.; Nong, X.; Qi, S. Alkaloids and citrinins from marine-derived fungus Nigrospora oryzae SCSGAF 0111. Tetrahedron Lett. 2014, 55, 2749–2753. [Google Scholar] [CrossRef]
  17. Chen, M.; Fu, X.; Kong, C.; Wang, C. Nucleoside derivatives from the marine-derived fungus Aspergillus versicolor. Nat. Prod. Res. 2014, 28, 895–900. [Google Scholar] [CrossRef] [PubMed]
  18. Liu, Z.; Xia, G.; Chen, S.; Liu, Y.; Li, H.; She, Z. Eurothiocin A and B, sulfur-containing benzofurans from a soft coral-derived fungus Eurotium rubrum SH-823. Mar. Drugs 2014, 12, 3669–3680. [Google Scholar] [CrossRef] [PubMed]
  19. Li, H.; Jiang, W.; Liang, W.; Huang, J.; Mo, Y.; Ding, Y.; Lam, C.; Qian, X.; Zhu, X.; Lan, W. Induced marine fungus Chondrostereum sp. as a means of producing new sesquiterpenoids chondrosterins I and J by using glycerol as the carbon source. Mar. Drugs 2014, 12, 167–175. [Google Scholar] [CrossRef] [PubMed]
  20. Chen, M.; Wang, K.; Liu, M.; She, Z.; Wang, C. Bioactive steroid derivatives and butyrolactone derivatives from a gorgonian-derived Aspergillus sp. fungus. Chem. Biodivers. 2015, 12, 1398–1406. [Google Scholar] [CrossRef] [PubMed]
  21. Chen, M.; Han, L.; Shao, C.; She, Z.; Wang, C. Bioactive diphenyl ether derivatives from a gorgonian-derived fungus Talaromyces sp. Chem. Biodivers. 2015, 12, 443–450. [Google Scholar] [CrossRef] [PubMed]
  22. Liang, W.; Le, X.; Li, H.; Yang, X.; Chen, J.; Xu, J.; Liu, H.; Wang, L.; Wang, K.; Hu, K.; et al. Exploring the chemodiversity and biological activities of the secondary metabolites from the marine fungus Neosartorya Pseudofischeri. Mar. Drugs 2014, 12, 5657–5676. [Google Scholar] [CrossRef] [PubMed]
  23. Lan, W.; Liu, W.; Liang, W.; Xu, Z.; Le, X.; Xu, J.; Lam, C.K.; Yang, D.; Li, H.; Wang, L. Pseudaboydins A and B: Novel isobenzofuranone derivatives from marine fungus Pseudallescheria boydii associated with starfish Acanthaster planci. Mar. Drugs 2014, 12, 4188–4199. [Google Scholar] [CrossRef] [PubMed]
  24. Du, F.; Zhang, P.; Li, X.; Li, C.; Cui, C.; Wang, B. Cyclohexadepsipeptides of the isaridin class from the marine-derived fungus Beauveria felina EN-135. J. Nat. Prod. 2014, 77, 1164–1169. [Google Scholar] [CrossRef] [PubMed]
  25. Du, F.; Li, X.; Zhang, P.; Li, C.; Wang, B. Cyclodepsipeptides and other o-containing heterocyclic metabolites from Beauveria felina EN-135, a marine-derived entomopathogenic fungus. Mar. Drugs 2014, 12, 2816–2826. [Google Scholar] [CrossRef] [PubMed]
  26. Quang, T.H.; Ngan, T.T.N.; Ko, W.; Kim, D.C.; Yoon, S.C.; Sohn, J.H.; Yim, J.H.; Kim, Y.C.; Oh, H. Tanzawaic acid derivatives from a marine isolate of Penicillium sp. (SF-6013) with anti-inflammatory and PTP1B inhibitory activities. Bioorg. Med. Chem. Lett. 2014, 24, 5787–5791. [Google Scholar] [CrossRef] [PubMed]
  27. Zhu, T.; Chen, Z.; Liu, P.; Wang, Y.; Xin, Z.; Zhu, W. New rubrolides from the marine-derived fungus Aspergillus Terreus OUCMDZ-1925. J. Antibiot. 2014, 67, 315–318. [Google Scholar] [CrossRef] [PubMed]
  28. Sun, K.; Li, Y.; Guo, L.; Wang, Y.; Liu, P.; Zhu, W. Indole diterpenoids and isocoumarin from the fungus, Aspergillus flavus, isolated from the prawn, Penaeus vannamei. Mar. Drugs 2014, 12, 3970–3981. [Google Scholar] [CrossRef] [PubMed]
  29. Yang, X.; Kang, M.; Li, Y.; Kim, E.A.; Kang, S.; Jeon, Y.J. Anti-inflammatory activity of questinol isolated from marine-derived fungus Eurotium amstelodami in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Microbiol. Biotechnol. 2014, 24, 1346–1353. [Google Scholar] [CrossRef] [PubMed]
  30. Liu, Y.; Zhao, S.; Ding, W.; Wang, P.; Yang, X.; Xu, J. Methylthio-aspochalasins from a marine-derived fungus Aspergillus sp. Mar. Drugs 2014, 12, 5124–5131. [Google Scholar] [CrossRef] [PubMed]
  31. Murshid, S.S.A.; Badr, J.M.; Youssef, D.T.A. Penicillosides A and B: New cerebrosides from the marine-derived fungus Penicillium species. Rev. Bras. Farmacogn. 2016, 26, 29–33. [Google Scholar] [CrossRef]
  32. Ma, Y.; Li, J.; Huang, M.; Liu, L.; Wang, J.; Lin, Y. Six new polyketide decalin compounds from mangrove endophytic fungus Penicillium aurantiogriseum 328#. Mar. Drugs 2015, 13, 6306–6318. [Google Scholar] [PubMed]
  33. Liu, Y.; Chen, S.; Liu, Z.; Lu, Y.; Xia, G.; Liu, H.; He, L.; She, Z. Bioactive metabolites from mangrove endophytic fungus Aspergillus sp. 16–5B. Mar. Drugs 2015, 13, 3091–3102. [Google Scholar] [CrossRef] [PubMed]
  34. Zhang, P.; Meng, L.; Mandi, A.; Kurtan, T.; Li, X.; Liu, Y.; Li, X.; Li, C.; Wang, B. Brocaeloids A–C, 4-oxoquinoline and indole alkaloids with C-2 reversed prenylation from the mangrove-derived endophytic fungus Penicillium brocae. Eur. J. Org. Chem. 2014, 19, 4029–4036. [Google Scholar] [CrossRef]
  35. Kong, F.; Wang, Y.; Liu, P.; Dong, T.; Zhu, W. Thiodiketopiperazines from the marine-derived fungus Phoma sp. OUCMDZ-1847. J. Nat. Prod. 2014, 77, 132–137. [Google Scholar] [CrossRef] [PubMed]
  36. Meng, L.; Li, X.; Lu, C.; Huang, C.; Wang, B. Brocazines A–F, cytotoxic bisthiodiketopiperazine derivatives from Penicillium brocae MA-231, an endo-phytic fungus derived from the marine mangrove plant Avicennia marina. J. Nat. Prod. 2014, 77, 1921–1927. [Google Scholar] [CrossRef] [PubMed]
  37. Yang, J.; Qiu, S.; She, Z.; Lin, Y. A new isochroman derivative from the marine fungus Phomopsis sp. (No.Gx-4). Chem. Nat. Compd. 2014, 50, 424–426. [Google Scholar] [CrossRef]
  38. Meng, L.; Zhang, P.; Li, X.; Wang, B. Penicibrocazines A–E, five new sulfide diketopiperazines from the marine-derived endophytic fungus Penicillium brocae. Mar. Drugs 2015, 13, 276–287. [Google Scholar] [CrossRef] [PubMed]
  39. Li, H.; Jiang, J.; Liu, Z.; Lin, S.; Xia, G.; Xia, X.; Ding, B.; He, L.; Lu, Y.; She, Z. Peniphenones A–D from the mangrove fungus Penicillium dipodomyicola HN4-3A as inhibitors of Mycobacterium tuberculosis Phosphatase MptpB. J. Nat. Prod. 2014, 77, 800–806. [Google Scholar] [CrossRef] [PubMed]
  40. Luo, H.; Li, X.; Li, C.; Wang, B. Diphenyl ether and benzophenone derivatives from the marine mangrove-derived fungus Penicillium sp. MA-37. Phytochem. Lett. 2014, 9, 22–25. [Google Scholar] [CrossRef]
  41. Wang, J.; Wei, X.; Lu, X.; Xu, F.; Wan, J.; Lin, X.; Zhou, X.; Liao, S.; Yang, B.; Tu, Z.; Liu, Y. Eight new polyketide metabolites from the fungus Pestalotiopsis vaccinii endogenous with the mangrove plant Kandelia candel (L.) Druce. Tetrahedron 2014, 70, 9695–9701. [Google Scholar] [CrossRef]
  42. Zhou, X.; Lin, X.; Ma, W.; Fang, W.; Chen, Z.; Yang, B.; Liu, Y. A new aromatic amine from fungus Pestalotiopsis vaccinii. Phytochem. Lett. 2014, 7, 35–37. [Google Scholar] [CrossRef]
  43. Kornsakulkarn, J.; Saepua, S.; Komwijit, S.; Rachtawee, P.; Thongpanchang, C. Bioactive polyketides from the fungus Astrocystis sp. BCC 22166. Tetrahedron 2014, 70, 2129–2133. [Google Scholar] [CrossRef]
  44. Bai, Z.; Lin, X.; Wang, Y.; Wang, J.; Zhou, X.; Yang, B.; Liu, J.; Yang, X.; Wang, Y.; Liu, Y. New phenyl derivatives from endophytic fungus Aspergillus flavipes AIL8 derived of mangrove plant Acanthus ilicifolius. Fitoterapia 2014, 95, 194–202. [Google Scholar] [CrossRef] [PubMed]
  45. Wang, J.; Wei, X.; Qin, X.; Chen, P.; Lin, X.; Zhang, T.; Yang, X.; Liao, S.; Yang, B.; Liu, J.; Zhou, X.; Tu, Z.; Liu, Y. Two new prenylated phenols from endogenous fungus Pestalotiopsis vaccinii of mangrove plant Kandelia candel (L.) Druce. Phytochem. Lett. 2015, 12, 59–62. [Google Scholar] [CrossRef]
  46. Meng, L.; Li, X.; Liu, Y.; Wang, B. Penicibilaenes A and B, sesquiterpenes with a tricyclo[6.3.1.0(1,5)]dodecane skeleton from the marine isolate of Penicillium bilaiae MA-267. Org. Lett. 2014, 16, 6052–6055. [Google Scholar] [CrossRef] [PubMed]
  47. Wang, J.; Cox, D.G.; Ding, W.; Huang, G.; Lin, Y.; Li, C. Three new resveratrol derivatives from the mangrove endophytic fungus Alternaria sp. Mar. Drugs 2014, 12, 2840–2850. [Google Scholar] [CrossRef] [PubMed]
  48. Huang, S.; Ding, W.; Li, C.; Cox, D.G. Two new cyclopeptides from the co-culture broth of two marine mangrove fungi and their antifungal activity. Pharmacogn. Mag. 2014, 10, 410–414. [Google Scholar] [PubMed]
  49. Li, C.; Wang, J.; Luo, C.; Ding, W.; Cox, D.G. A new cyclopeptide with antifungal activity from the co-culture broth of two marine mangrove fungi. Nat. Prod. Res. 2014, 28, 616–621. [Google Scholar] [CrossRef] [PubMed]
  50. Peng, J.; Zhang, X.; Du, L.; Wang, W.; Zhu, T.; Cu, Q.; Li, D. Sorbicatechols A and B, antiviral sorbicillinoids from the marine-derived fungus Penicillium chrysogenum PJX-17. J. Nat. Prod. 2014, 77, 424–428. [Google Scholar] [CrossRef] [PubMed]
  51. Liao, L.; Lee, J.H.; You, M.J.; Choi, T.J.; Park, W.; Lee, S.K.; Oh, D.C.; Oh, K.B.; Shin, J. Penicillipyrones A and B, meroterpenoids from a marine-derived Penicillium sp. fungus. J. Nat. Prod. 2014, 77, 406–410. [Google Scholar] [CrossRef] [PubMed]
  52. Orfali, R.S.; Aly, A.H.; Ebrahim, W.; Abdel-Aziz, M.S.; Müller, W.E.G.; Lin, W.H.; Daletos, G.; Proksch, P. Pretrichodermamide C and N-methylpretrichodermamide B, two new cytotoxic epidithiodiketopiperazines from hyper saline lake derived Penicillium sp. Phytochem. Lett. 2015, 3, 168–172. [Google Scholar] [CrossRef]
  53. Yurchenko, A.N.; Smetanina, O.F.; Kalinovsky, A.I.; Pushilin, M.A.; Glazunov, V.P.; Khudyakova, Y.V.; Kirichuk, N.N.; Ermakova, S.P.; Dyshlovoy, S.A.; Yurchenko, E.A.; et al. Oxirapentyns F–K from the marine-sediment-derived fungus Isaria felina KMM 4639. J. Nat. Prod. 2014, 77, 1321–1328. [Google Scholar] [CrossRef] [PubMed]
  54. An, C.; Li, X.; Li, C.; Xu, G.; Wang, B. Prenylated indolediketopiperazine peroxides and related homologues from the marine sediment-derived fungus Penicillium brefeldianum SD-273. Mar. Drugs 2014, 12, 746–756. [Google Scholar] [CrossRef] [PubMed]
  55. Luan, Y.; Wei, H.; Zhang, Z.; Che, Q.; Liu, Y.; Zhu, T.; Mandi, A.; Kurtan, T.; Gu, Q.; Li, D. Eleganketal A, a highly oxygenated dibenzospiroketal from the marine-derived fungus Spicaria elegans KLA03. J. Nat. Prod. 2014, 77, 1718–1723. [Google Scholar] [CrossRef] [PubMed]
  56. Hu, X.; Xia, Q.; Zhao, Y.; Zheng, Q.; Liu, Q.; Chen, L.; Zhang, Q. Speradines F–H, three new oxindole alkaloids from the marine-derived fungus Aspergillus oryzae. Chem. Pharm. Bull. 2014, 62, 942–946. [Google Scholar] [CrossRef] [PubMed]
  57. Peng, J.; Gao, H.; Zhang, X.; Wang, S.; Wu, C.; Gu, Q.; Guo, P.; Zhu, T.; Li, D. Psychrophilins E–H and versicotide C, cyclic peptides from the marine-derived fungus Aspergillus versicolor ZLN-60. J. Nat. Prod. 2014, 77, 2218–2223. [Google Scholar] [CrossRef] [PubMed]
  58. Li, C.; Li, X.; An, C.; Wang, B. Prenylated indole alkaloid derivatives from marine sediment-derived fungus Penicillium paneum SD-44. Helvetica. Chim. Acta 2014, 97, 1440–1444. [Google Scholar] [CrossRef]
  59. Peng, J.; Gao, H.; Li, J.; Ai, J.; Geng, M.; Zhang, G.; Zhu, T.; Gu, Q.; Li, D. Prenylated indole diketopiperazines from the marine-derived fungus Aspergillus versicolor. J. Org. Chem. 2014, 79, 7895–7904. [Google Scholar] [CrossRef] [PubMed]
  60. Fang, S.; Wu, C.; Li, C.; Cui, C. A practical strategy to discover new antitumor compounds by activating silent metabolite production in fungi by diethyl sulphate mutagenesis. Mar. Drugs 2014, 12, 1788–1814. [Google Scholar] [CrossRef] [PubMed]
  61. Xia, M.; Cui, C.; Li, C.; Wu, C. Three new and eleven known unusual C25 steroids: Activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1545–1568. [Google Scholar] [CrossRef] [PubMed]
  62. Wu, C.; Li, C.; Cui, C. Seven new and two known lipopeptides as well as five known polyketides: The activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1815–1838. [Google Scholar] [CrossRef] [PubMed]
  63. Wang, W.; Li, D.; Li, Y.; Hua, H.; Ma, E.; Li, Z. Caryophyllene sesquiterpenes from the marine-derived fungus Ascotricha sp. ZJ-M-5 by the one strain-many compounds strategy. J. Nat. Prod. 2014, 77, 1367–1371. [Google Scholar] [CrossRef] [PubMed]
  64. Gu, B.; Zhang, Y.; Ding, L.; He, S.; Wu, B.; Dong, J.; Zhu, P.; Chen, J.; Zhang, J.; Yan, X. Preparative separation of sulfur-containing diketopiperazines from marine fungus Cladosporium sp. using high-speed counter-current chromatography in stepwise elution mode. Mar. Drugs 2015, 13, 354–365. [Google Scholar] [CrossRef] [PubMed]
  65. Zhou, X.; Fang, P.; Tang, J.; Wu, Z.; Li, X.; Li, S.; Wang, Y.; Liu, G.; He, Z.; Gou, D.; et al. A novel cyclic dipeptide from deep marine-derived fungus Aspergillus sp. SCSIOW2. Nat. Prod. Res. 2016, 30, 52–57. [Google Scholar] [CrossRef] [PubMed]
  66. Sun, Y.; Wang, J.; Wang, Y.; Zhang, X.; Nong, X.; Chen, M.; Xu, X.; Qi, S. Cytotoxic and antiviral tetramic acid derivatives from the deep-sea-derived fungus Trichobotrys effus DFFSCS021. Tetrahedron 2015, 71, 9328–9332. [Google Scholar] [CrossRef]
  67. Liu, X.; Miao, F.; Liang, X.; Ji, N. Ergosteroid derivatives from an algicolous strain of Aspergillus ustus. Nat. Prod. Res. 2014, 28, 1182–1186. [Google Scholar] [CrossRef] [PubMed]
  68. Zhuravleva, O.I.; Sobolevskaya, M.P.; Afiyatullov, S.S.; Kirichuk, N.N.; Denisenko, V.A.; Dmitrenok, P.S.; Yurchenko, E.A.; Dyshlovoy, S.A. Sargassopenillines A–G, 6,6-spiroketals from the alga-derived fungi Penicillium thomii and Penicillium lividum. Mar. Drugs 2014, 12, 5930–5943. [Google Scholar] [CrossRef] [PubMed]
  69. Zhuravleva, O.I.; Sobolevskaya, M.P.; Leshchenko, E.V.; Kirichuk, N.N.; Denisenko, V.A.; Dmitrenok, P.S.; Dyshlovoy, S.A.; Zakharenko, A.M.; Kim, N.Y.; Afiyatullov, S.S. Meroterpenoids from the alga-derived fungi Penicillium thomii maire and Penicillium lividum westling. J. Nat. Prod. 2014, 77, 1390–1395. [Google Scholar] [CrossRef] [PubMed]
  70. Li, X.; Miao, F.; Liang, X.; Ji, N. Meroterpenes from an algicolous strain of Penicillium echinulatum. Magn. Reson. Chem. 2014, 52, 247–250. [Google Scholar] [CrossRef] [PubMed]
  71. Fang, W.; Lin, X.; Zhou, X.; Wan, J.; Lu, X.; Yang, B.; Ai, W.; Lin, J.; Zhang, T.; Tu, Z.; Liu, Y. Cytotoxic and antiviral nitrobenzoyl sesquiterpenoids from the marine-derived fungus Aspergillus ochraceus Jcma1F17. Med. Chem. Commun. 2014, 5, 701–705. [Google Scholar] [CrossRef]
  72. Zhang, P.; Mandi, A.; Li, X.; Du, F.; Wang, J.; Li, X.; Kurtan, T.; Wang, B. Varioxepine A, a 3H-oxepine-containing alkaloid with a new oxa-cage from the marine algal-derived endophytic fungus Paecilomyces variotii. Org. Lett. 2014, 16, 4834–4837. [Google Scholar] [CrossRef] [PubMed]
  73. Zhang, P.; Li, X.; Wang, J.; Li, X.; Wang, B. New butenolide derivatives from the marine-derived fungus Paecilomyces variotii with DPPH radical scavenging activity. Phytochem. Lett. 2015, 11, 85–88. [Google Scholar] [CrossRef]
  74. Li, X.; Li, X.; Xu, G.; Li, C.; Wang, B. Antioxidant metabolites from marine alga-derived fungus Aspergillus wentii EN-48. Phytochem. Lett. 2014, 7, 120–123. [Google Scholar] [CrossRef]
  75. Zhang, P.; Li, X.; Wang, J.; Wang, B. Oxepine-containing diketopiperazine alkaloids from the algal-derived endophytic fungus Paecilomyces variotii EN-291. Helv. Chim. Acta 2015, 98, 800–804. [Google Scholar] [CrossRef]
  76. Alarif, W.M.; Al-Footy, K.O.; Zubair, M.S.; Halid Ph, M.; Ghandourah, M.A.; Basaif, S.A.; Al-Lihaibi, S.S.; Ayyad, S.N.; Badria, F.A. The role of new eudesmane-type sesquiterpenoid and known eudesmane derivatives from the red alga Laurencia obtusa as potential antifungal-antitumour agents. Nat. Prod. Res. 2015, 20, 1–6. [Google Scholar]
  77. Wu, B.; Oesker, V.; Wiese, J.; Schmaljohann, R.; Imhoff, J.F. Two new antibiotic pyridones produced by a marine fungus, Trichoderma sp. strain MF106. Mar. Drugs 2014, 12, 1208–1219. [Google Scholar] [CrossRef] [PubMed]
  78. Li, J.; Yang, X.; Lin, Y.; Yuan, J.; Lu, Y.; Zhu, X.; Li, J.; Li, M.; Lin, Y.; He, J.; Liu, L. Meroterpenes and azaphilones from marine mangrove endophytic fungus Penicillium 303#. Fitoterapia 2014, 97, 241–246. [Google Scholar] [PubMed]
  79. Wu, B.; Oesker, V.; Wiese, J.; Malien, S.; Schmaljohann, R.; Imhoff, J.F. Spirocyclic drimanes from the marine fungus Stachybotrys sp. strain MF347. Mar. Drugs 2014, 12, 1924–1938. [Google Scholar] [CrossRef] [PubMed]
  80. He, J.; Ji, Y.; Hu, D.; Zhang, S.; Yan, H.; Liu, X.; Luo, H.; Zhu, H. Structure and absolute configuration of penicilliumine, a new alkaloid from Penicillium commune 366606. Tetrahedron Lett. 2014, 55, 2684–2686. [Google Scholar] [CrossRef]
  81. Wang, J.; Zhao, Y.; Men, L.; Zhang, Y.; Liu, Z.; Sun, T.; Geng, Y.; Yu, Z. Secondary metabolites of the marine fungus Penicillium chrysogenum. Chem. Nat. Compd. 2014, 50, 405–407. [Google Scholar] [CrossRef]
  82. Xiao, Z.; Lin, S.; Tan, C.; Lu, Y.; He, L.; Huang, X.; She, Z. Asperlones A and B, dinaphthalenone derivatives from a mangrove endophytic fungus Aspergillus sp. 16–5C. Mar. Drugs 2015, 13, 366–378. [Google Scholar] [CrossRef] [PubMed]
  83. Hussain, H.; Root, N.; Jabeen, F.; Al-Harrasi, A.; Ahmad, M.; Mabood, F.; Hassan, Z.; Shah, A.; Green, I.R.; Schulz, B.; et al. Microsphaerol and seimatorone: Two new compounds isolated from the endophytic fungi, Microsphaeropsis sp. and Seimatosporium sp. Chem. Biodivers. 2015, 12, 289–294. [Google Scholar] [CrossRef] [PubMed]
  84. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2014, 31, 160–258. [Google Scholar] [CrossRef] [PubMed]
  85. Imhoff, J.F. Natural products from marine fungi—Still an underrepresented resource. Mar. Drugs 2016, 14, 1–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Williams, R.B.; Henrikson, J.C.; Hoover, A.R.; Lee, A.E.; Cichewicz, R.H. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 2008, 6, 1895–1897. [Google Scholar] [CrossRef] [PubMed]
  87. Chung, Y.; Wei, C.; Chuang, D.; El-Shazly, M.; Hsieh, C.T.; Asai, T.; Oshima, Y.; Hsieh, T.J.; Hwang, T.L.; Wu, Y.; et al. An epigenetic modifier enhances the production of anti-diabetic and anti-inflammatory sesquiterpenoids from Aspergillus sydowii. Bioorg. Med. Chem. 2013, 21, 3866–3872. [Google Scholar] [CrossRef] [PubMed]
  88. Beau, J.; Mahid, N.; Burda, W.N.; Harrington, L.; Shaw, L.N.; Mutka, T.; Kyle, D.E.; Barisic, B.; Olphen, A.; Baker, B.J. Epigenetic tailoring for the production of anti- infective cytosporones from the marine fungus Leucostoma persoonii. Mar. Drugs 2012, 10, 762–774. [Google Scholar] [CrossRef] [PubMed]
  89. Bhatnagar, I.; Kim, S.K. Immense essence of excellence: Marine microbial bioactive compounds. Mar. Drugs 2010, 8, 2673–2701. [Google Scholar] [CrossRef] [PubMed]
  90. Duarte, K.; Rocha-Santos, T.A.P.; Freitas, A.C.; Duarte, A.C. Analytical techniques for discovery of bioactive compounds from marine fungi. Trends Anal. Chem. 2012, 34, 97–110. [Google Scholar] [CrossRef]
Figure 1. Structures of compounds 12.
Figure 1. Structures of compounds 12.
Marinedrugs 14 00076 g001
Figure 2. Structures of compounds 39.
Figure 2. Structures of compounds 39.
Marinedrugs 14 00076 g002
Figure 3. Structures of compounds 1014.
Figure 3. Structures of compounds 1014.
Marinedrugs 14 00076 g003
Figure 4. Structures of compounds 1518.
Figure 4. Structures of compounds 1518.
Marinedrugs 14 00076 g004
Figure 5. Structures of compounds 1920.
Figure 5. Structures of compounds 1920.
Marinedrugs 14 00076 g005
Figure 6. Structures of compounds 2124.
Figure 6. Structures of compounds 2124.
Marinedrugs 14 00076 g006
Figure 7. Structures of compounds 2529.
Figure 7. Structures of compounds 2529.
Marinedrugs 14 00076 g007
Figure 8. Structures of compounds 3031.
Figure 8. Structures of compounds 3031.
Marinedrugs 14 00076 g008
Figure 9. Structures of compounds 3237.
Figure 9. Structures of compounds 3237.
Marinedrugs 14 00076 g009
Figure 10. Structures of compounds 3840.
Figure 10. Structures of compounds 3840.
Marinedrugs 14 00076 g010
Figure 11. Structures of compounds 4146.
Figure 11. Structures of compounds 4146.
Marinedrugs 14 00076 g011
Figure 12. Structures of compounds 4752.
Figure 12. Structures of compounds 4752.
Marinedrugs 14 00076 g012
Figure 13. Structures of compounds 5360.
Figure 13. Structures of compounds 5360.
Marinedrugs 14 00076 g013
Figure 14. Structures of compounds 6166.
Figure 14. Structures of compounds 6166.
Marinedrugs 14 00076 g014
Figure 15. Structures of compounds 6771.
Figure 15. Structures of compounds 6771.
Marinedrugs 14 00076 g015
Figure 16. Structures of compounds 7275.
Figure 16. Structures of compounds 7275.
Marinedrugs 14 00076 g016
Figure 17. Structures of compounds 7682.
Figure 17. Structures of compounds 7682.
Marinedrugs 14 00076 g017
Figure 18. Structures of compounds 83–85.
Figure 18. Structures of compounds 83–85.
Marinedrugs 14 00076 g018
Figure 19. Structures of compounds 8688.
Figure 19. Structures of compounds 8688.
Marinedrugs 14 00076 g019
Figure 20. Structures of compounds 8991.
Figure 20. Structures of compounds 8991.
Marinedrugs 14 00076 g020
Figure 21. Structures of compounds 9294.
Figure 21. Structures of compounds 9294.
Marinedrugs 14 00076 g021
Figure 22. Structures of compounds 9598.
Figure 22. Structures of compounds 9598.
Marinedrugs 14 00076 g022
Figure 23. Structures of compounds 99112.
Figure 23. Structures of compounds 99112.
Marinedrugs 14 00076 g023
Figure 24. Structures of compounds 113116.
Figure 24. Structures of compounds 113116.
Marinedrugs 14 00076 g024
Figure 25. Structures of compounds 117120.
Figure 25. Structures of compounds 117120.
Marinedrugs 14 00076 g025
Figure 26. Structures of compounds 121126.
Figure 26. Structures of compounds 121126.
Marinedrugs 14 00076 g026
Figure 27. Structures of compounds 127133.
Figure 27. Structures of compounds 127133.
Marinedrugs 14 00076 g027
Figure 28. Structures of compounds 134136.
Figure 28. Structures of compounds 134136.
Marinedrugs 14 00076 g028
Figure 29. Structures of compounds 137139.
Figure 29. Structures of compounds 137139.
Marinedrugs 14 00076 g029
Figure 30. Structures of compounds 140142.
Figure 30. Structures of compounds 140142.
Marinedrugs 14 00076 g030
Figure 31. Structures of compounds 143146.
Figure 31. Structures of compounds 143146.
Marinedrugs 14 00076 g031
Figure 32. Structures of compounds 147149.
Figure 32. Structures of compounds 147149.
Marinedrugs 14 00076 g032
Figure 33. Structures of compounds 150153.
Figure 33. Structures of compounds 150153.
Marinedrugs 14 00076 g033
Figure 34. New compounds from marine-derived fungi included in this review, divided by sources of the fungal strains.
Figure 34. New compounds from marine-derived fungi included in this review, divided by sources of the fungal strains.
Marinedrugs 14 00076 g034
Figure 35. New compounds from marine-derived fungi included in this review, divided by structural types.
Figure 35. New compounds from marine-derived fungi included in this review, divided by structural types.
Marinedrugs 14 00076 g035
Figure 36. Bioactive categories of new compounds from marine-derived fungi included in this review.
Figure 36. Bioactive categories of new compounds from marine-derived fungi included in this review.
Marinedrugs 14 00076 g036

Share and Cite

MDPI and ACS Style

Jin, L.; Quan, C.; Hou, X.; Fan, S. Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi. Mar. Drugs 2016, 14, 76. https://doi.org/10.3390/md14040076

AMA Style

Jin L, Quan C, Hou X, Fan S. Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi. Marine Drugs. 2016; 14(4):76. https://doi.org/10.3390/md14040076

Chicago/Turabian Style

Jin, Liming, Chunshan Quan, Xiyan Hou, and Shengdi Fan. 2016. "Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi" Marine Drugs 14, no. 4: 76. https://doi.org/10.3390/md14040076

APA Style

Jin, L., Quan, C., Hou, X., & Fan, S. (2016). Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi. Marine Drugs, 14(4), 76. https://doi.org/10.3390/md14040076

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop